Infectious Disease Diagnostics Market worth $25.43 billion by 2027

The global infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%.

The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022.

Growth in this market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics.Industry Segmentation:Increased accessibility and the increasing number of IDD tests conducted are the key drivers for this segment.

Globally, the volume of IDD tests is increasing mainly due to the rising geriatric population; increasing prevalence of infectious diseases; increased variety of reagents available and analytical techniques employed; and the continuous launch of newer, faster, and more reliable products.Roche, Bio-Rad, and bioMérieux are some of the major players in the infectious disease diagnostics market for assays, kits, & reagents.Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589Factors such as advancements in sequencing technologies, increasing awareness and acceptance of personalized medicine (in which this technology has significant applications), and increasing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing are expected to boost the growth of this technology in the future.On the basis of disease type, the infectious disease diagnostics (IDD) market is segmented into a wide range of diseases.

Hospital acquired infections (HAI) segment to record the highest CAGR during the forecast period.

Growth in HAI segment can be attributed to the rising burden of MRSA infections, the increasing number of new products launched in the market, and increasing adoption of technologically advanced HAI diagnostic tests such as BD MAX Cdiff assay, Xpert MRSA NxG, and ARIES C. difficile Assay that are based on PCR technologyHepatitis diagnostics market formed the largest share.

Market Analysis and Insights:- Europe Infectious Disease Diagnostics MarketEurope Infectious Disease Diagnostics Market By Product & Service (Assays, Kits, Reagents, Instruments, Service & Software), Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray, Other Technologies), Disease Type (Hepatitis, HIV, CT/NG, HAIS, HPV, TB, Influenza, Other Infectious Diseases), End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users), Country (Germany, U.K., France, Spain, Italy, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2026Market Analysis: Europe Infectious Disease Diagnostics MarketEurope infectious disease diagnostics market is registering a substantial CAGR in the forecast period of 2019-2026.

The report contains data from the base year of 2018 and the historic year of 2017.

The rise in the market can be attributed due to the surging demand for new diagnostic tests for the control of infectious diseases is contributing to market growth.Market Definition: Europe Infectious Disease Diagnostics MarketInfectious disease diagnostics refers to the testing and diagnostic of presence of any infectious organisms in the body.

The tests whose kits are commonly available for sexually transmitted diseases and bacterial infections.

Infectious disease tests have a surging demand due to rising infectious disease among people and are usually done in the hospital, clinical laboratories, reference laboratories, physician offices and research institutes.Get More Insight About the Europe Infectious Disease Diagnostics Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-infectious-disease-diagnostics-market  Market DriversRising incidences of infectious diseases globally are driving the market growthThere has been a shift to decentralized point-of-care testing from centralized laboratories which is boosting the market growthThere has been a rise in the availability of funding and investment for the research in infectious disease which is fueling the market growthMarket RestraintsThe Inadequate reimbursements are hindering the market growthThe surging cost of the healthcare which is limiting the preference of a novel diagnostic technique is hampering the market growthThe various molecular techniques have emerged which is hindering the market growth Know More About this Report @ https://www.databridgemarketresearch.com/reports/europe-infectious-disease-diagnostics-market Segmentation: Europe Infectious Disease Diagnostics MarketBy Product & ServiceAssays, Kits, & ReagentsInstrumentsService & SoftwareBy TechnologyImmunodiagnosticsClinical MicrobiologyPolymerase Chain Reaction (PCR)Isothermal Nucleic Acid Amplification Technology (INAAT)DNA Sequencing & Next-Generation Sequencing (NGS)DNA MicroarrayOther TechnologiesBy Disease TypeHepatitisHuman Immunodeficiency Virus (HIV)Chlamydia trachomatis and Neisseria Gonorrhoeae (CT/NG)Hospital-Acquired Infections (HAIS)Human Papillomavirus (HPV)Tuberculosis (TB)InfluenzaOther Infectious DiseasesBy End UserHospital/Clinical LaboratoriesReference LaboratoriesPhysician OfficesAcademic/Research InstitutesOther End UsersBy CountryGermanyU.K.FranceSpainItalyRussiaTurkeyBelgiumNetherlandsSwitzerlandRest of EuropeCompetitive Analysis:Europe infectious disease diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

The report includesmarket shares of infectious disease diagnostics market for Germany, U.K., France, Spain, Italy, Russia, Turkey, Belgium, Netherlands, Switzerland and Rest of Europe.Key Market Competitors:Few of the major market competitors currently working in the Europe Infectious Disease Diagnostics Market are Abbott, Thermo Fisher Scientific, BD, Danaher, Johnson & Johnson Services Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, bioMérieux SA, Medtronic, Novartis AG, Siemens, Quidel Corporation, Mobidiag Ltd., Meridian Bioscience Europe B.V., Luminex Corporation, Sofina, Ingersoll-Rand plc and DiaSorin S.p.A., among others.Research Methodology: Europe Infectious Disease Diagnostics MarketData collection and base year analysis is done using data collection modules with large sample sizes.

This Infectious Disease Diagnostics Market research report has several benefits which can be projected to varied aspects of Infectious Disease Diagnostics industry.

In this report, market is segmented based on mainly type, application, and region.

The report includes market analysis based on regional as well as global level.

Moreover, this Infectious Disease Diagnostics report serves the purpose of validating the information that has been gathered through internal or primary research.The report describes estimations of CAGR values, market drivers and market restraints about the Infectious Disease Diagnostics industry which is helpful for businesses in deciding upon numerous strategies.

This Infectious Disease Diagnostics Market report takes into account diverse segments of the market analysis that today’s business ask for.Get Download Free Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-infectious-disease-diagnostics-marketThe research studies brought about in this Infectious Disease Diagnostics report helps to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share.

The strategies covered here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market.Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.

According to the new market research report " Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) - Global Forecast to 2022 ", published by MarketsandMarkets™, The global infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%.Access Free Sample Research Copy : https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589What Drives the Market?Growth in this market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnosticsGeographical Growth Analysis:North America accounted for the largest share of the global market.

This large share can be attributed to the presence of a highly developed healthcare system, increasing prevalence of infectious diseases, the presence of a large number of leading national clinical laboratories, and easy accessibility to technologically advanced instruments in the region.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589Global Market Segmentation:The market is broadly segmented into assays, kits, & reagents; instruments; and services & software based on product & service.

The assays, kits, & reagents segment accounted for the largest share of the global market and is expected to register the highest CAGR during the forecast period.

The increasing number of infectious disease diagnostic tests carried out; easy accessibility to a wide range of reagents; and the growing need for reliable, specific, and faster detection of infectious diseases in the early stages are the key factors driving the IDD assays, kits, & reagents market.Based on the disease type, the market is segmented into hepatitis, HIV, HAIs, CT/NG, HPV, TB, Influenza, and other diseases.

The hepatitis diagnostics segment accounted for the largest share of the global market in 2017.

The dominant share of this segment can be attributed to the rising prevalence of hepatitis B and C, the availability of a large number of hepatitis diagnostic tests, and increasing number of HIV/Hepatitis co-infections.Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589

Market Analysis and Insights:- Europe Infectious Disease Diagnostics MarketEurope Infectious Disease Diagnostics Market By Product & Service (Assays, Kits, Reagents, Instruments, Service & Software), Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray, Other Technologies), Disease Type (Hepatitis, HIV, CT/NG, HAIS, HPV, TB, Influenza, Other Infectious Diseases), End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users), Country (Germany, U.K., France, Spain, Italy, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2026Market Analysis: Europe Infectious Disease Diagnostics MarketEurope infectious disease diagnostics market is registering a substantial CAGR in the forecast period of 2019-2026.

The report contains data from the base year of 2018 and the historic year of 2017.

The rise in the market can be attributed due to the surging demand for new diagnostic tests for the control of infectious diseases is contributing to market growth.Market Definition: Europe Infectious Disease Diagnostics MarketInfectious disease diagnostics refers to the testing and diagnostic of presence of any infectious organisms in the body.

The tests whose kits are commonly available for sexually transmitted diseases and bacterial infections.

Infectious disease tests have a surging demand due to rising infectious disease among people and are usually done in the hospital, clinical laboratories, reference laboratories, physician offices and research institutes.Get More Insight About the Europe Infectious Disease Diagnostics Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-infectious-disease-diagnostics-market  Market DriversRising incidences of infectious diseases globally are driving the market growthThere has been a shift to decentralized point-of-care testing from centralized laboratories which is boosting the market growthThere has been a rise in the availability of funding and investment for the research in infectious disease which is fueling the market growthMarket RestraintsThe Inadequate reimbursements are hindering the market growthThe surging cost of the healthcare which is limiting the preference of a novel diagnostic technique is hampering the market growthThe various molecular techniques have emerged which is hindering the market growth Know More About this Report @ https://www.databridgemarketresearch.com/reports/europe-infectious-disease-diagnostics-market Segmentation: Europe Infectious Disease Diagnostics MarketBy Product & ServiceAssays, Kits, & ReagentsInstrumentsService & SoftwareBy TechnologyImmunodiagnosticsClinical MicrobiologyPolymerase Chain Reaction (PCR)Isothermal Nucleic Acid Amplification Technology (INAAT)DNA Sequencing & Next-Generation Sequencing (NGS)DNA MicroarrayOther TechnologiesBy Disease TypeHepatitisHuman Immunodeficiency Virus (HIV)Chlamydia trachomatis and Neisseria Gonorrhoeae (CT/NG)Hospital-Acquired Infections (HAIS)Human Papillomavirus (HPV)Tuberculosis (TB)InfluenzaOther Infectious DiseasesBy End UserHospital/Clinical LaboratoriesReference LaboratoriesPhysician OfficesAcademic/Research InstitutesOther End UsersBy CountryGermanyU.K.FranceSpainItalyRussiaTurkeyBelgiumNetherlandsSwitzerlandRest of EuropeCompetitive Analysis:Europe infectious disease diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

The report includesmarket shares of infectious disease diagnostics market for Germany, U.K., France, Spain, Italy, Russia, Turkey, Belgium, Netherlands, Switzerland and Rest of Europe.Key Market Competitors:Few of the major market competitors currently working in the Europe Infectious Disease Diagnostics Market are Abbott, Thermo Fisher Scientific, BD, Danaher, Johnson & Johnson Services Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, bioMérieux SA, Medtronic, Novartis AG, Siemens, Quidel Corporation, Mobidiag Ltd., Meridian Bioscience Europe B.V., Luminex Corporation, Sofina, Ingersoll-Rand plc and DiaSorin S.p.A., among others.Research Methodology: Europe Infectious Disease Diagnostics MarketData collection and base year analysis is done using data collection modules with large sample sizes.